Upcoming treatments for morphea
Abstract Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4–2.7 cases per 100,000. Morphea occurs most frequently in children aged 2–14 years, and the disease exhibits a female predominance. Insights in...
Saved in:
Main Authors: | Dan Wenzel, Nazgol‐Sadat Haddadi, Khashayar Afshari, Jillian M. Richmond, Mehdi Rashighi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-12-01
|
Series: | Immunity, Inflammation and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1002/iid3.475 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical case of morphea associated with a malignant process with extensive skin lesions, which debuted against the background of taking anti-gouty remedy
by: P. O. Kazakova
Published: (2024-11-01) -
Juvenile Localized Scleroderma from the Perspective of Pediatric Rheumatologist. Aspects of Diagnostics
by: Rinat K. Raupov, et al.
Published: (2020-06-01) -
Frequency of occurrenceof tumor-associated localized scleroderma
by: P. O. Kazakova
Published: (2025-05-01) -
Response to Mazori et al, “Overlap of generalized morphea and eosinophilic fasciitis after recreational exposure to epoxy resin”
by: Noah Hewitt, MD, et al.
Published: (2025-08-01) -
Juvenile Localized Scleroderma. Questions of Treatment
by: Rinat K. Raupov, et al.
Published: (2020-08-01)